• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞通过激活ID1促进胆管癌进展和化疗耐药。

Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1.

作者信息

Guo Yinghao, Miao Shuangda, Jin Yun, Li Qi, Wang Yihang, Zhang Xiaoxiao, Li Jiangtao

机构信息

Department of Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, China.

Department of Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, China.

出版信息

Ann Hepatol. 2025 Jan-Jun;30(1):101773. doi: 10.1016/j.aohep.2024.101773. Epub 2024 Dec 12.

DOI:10.1016/j.aohep.2024.101773
PMID:39674368
Abstract

INTRODUCTION AND OBJECTIVES

Tumor-associated macrophages (TAM) can influence both cancer growth and chemoresistance, but the specific mechanisms involved in these processes in cholangiocarcinoma (CCA) are unclear.

MATERIALS AND METHODS

We explored the distribution of TAM in CCA samples by multiplex immunofluorescence staining and tested the effects of TAM on CCA in vitro and in vivo. We then investigated the mechanisms underlying these effects using the Luminex assay, RNA sequencing, western blotting, flow cytometry, and co-immunoprecipitation.

RESULTS

The infiltration of TAM was strongly increased in the cholangiocarcinoma tumor microenvironment. Oncostain M (OSM) secreted by TAM increased the proliferation and chemotherapeutic resistance of CCA cells both in vitro and in vivo. The results of transcriptome sequencing analysis, Western blot analysis, and immunofluorescence staining confirmed that OSM can promote Yap nuclear translocation and its subsequent formation of complexes with SMADs to upregulate the expression of inhibitor of DNA binding 1 (ID1).

CONCLUSIONS

TAM promotes CCA progression and chemoresistance through activating OSM-Yap-ID1.

摘要

引言与目的

肿瘤相关巨噬细胞(TAM)可影响癌症生长和化疗耐药性,但这些过程在胆管癌(CCA)中所涉及的具体机制尚不清楚。

材料与方法

我们通过多重免疫荧光染色探究了TAM在CCA样本中的分布,并在体外和体内测试了TAM对CCA的影响。然后,我们使用Luminex检测、RNA测序、蛋白质免疫印迹、流式细胞术和免疫共沉淀研究了这些影响的潜在机制。

结果

在胆管癌肿瘤微环境中,TAM的浸润显著增加。TAM分泌的抑瘤素M(OSM)在体外和体内均增加了CCA细胞的增殖和化疗耐药性。转录组测序分析、蛋白质免疫印迹分析和免疫荧光染色结果证实,OSM可促进Yes相关蛋白(Yap)核转位及其随后与SMAD蛋白形成复合物以上调DNA结合抑制因子1(ID1)的表达。

结论

TAM通过激活OSM-Yap-ID1促进CCA进展和化疗耐药。

相似文献

1
Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1.肿瘤相关巨噬细胞通过激活ID1促进胆管癌进展和化疗耐药。
Ann Hepatol. 2025 Jan-Jun;30(1):101773. doi: 10.1016/j.aohep.2024.101773. Epub 2024 Dec 12.
2
Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.肿瘤相关中性粒细胞和巨噬细胞的相互作用通过激活 STAT3 促进肝内胆管癌的进展。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001946.
3
MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5.MBD2 通过与 WDR5 的相互作用调控胆管癌的进展和化疗耐药性。
J Exp Clin Cancer Res. 2024 Sep 30;43(1):272. doi: 10.1186/s13046-024-03188-4.
4
Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.针对双皮质素样激酶 1 高表达的胆管癌患者,靶向 PI3K/AKT/mTOR 通路提供了一种有前景的治疗策略。
J Cancer Res Clin Oncol. 2024 Jul 9;150(7):342. doi: 10.1007/s00432-024-05875-3.
5
The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines.酸性细胞外pH条件下OCT4的上调与胆管癌细胞系中吉西他滨耐药相关。
Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2745-2748. doi: 10.31557/APJCP.2019.20.9.2745.
6
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis.β-连环蛋白介导的肿瘤相关巨噬细胞表型通过OSM/STAT3/LOXL2轴促进胰腺癌转移。
Neoplasia. 2025 Feb;60:101096. doi: 10.1016/j.neo.2024.101096. Epub 2024 Dec 30.
7
The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma.Yes 相关蛋白 (YAP) 的表达维持了肝内胆管癌的肿瘤干细胞特性,并与不良预后相关。
Am J Pathol. 2019 Sep;189(9):1863-1877. doi: 10.1016/j.ajpath.2019.05.014. Epub 2019 Jun 18.
8
The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.去泛素化酶 USP5 通过稳定 YBX1 促进胆管癌进展。
Life Sci. 2024 Jul 1;348:122674. doi: 10.1016/j.lfs.2024.122674. Epub 2024 Apr 29.
9
Targeting PDGF-CC as a promising therapeutic strategy to inhibit cholangiocarcinoma progression.针对 PDGF-CC 作为一种有前途的治疗策略,抑制胆管癌的进展。
J Transl Med. 2024 Nov 14;22(1):1023. doi: 10.1186/s12967-024-05857-6.
10
A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.PLCB1-PI3K-AKT 信号轴激活 EMT 促进胆管癌进展。
Cancer Res. 2021 Dec 1;81(23):5889-5903. doi: 10.1158/0008-5472.CAN-21-1538. Epub 2021 Sep 27.

引用本文的文献

1
Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers.患者来源的类器官在肝胆胰癌中的应用与挑战
World J Gastroenterol. 2025 May 28;31(20):106747. doi: 10.3748/wjg.v31.i20.106747.